NCT07512895 The Effect of Progressive Muscle Relaxation Exercises on Depression and Fatigue in Patients Receiving Hemodialysis Treatment: A Randomized Controlled Trial
| NCT ID | NCT07512895 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Istanbul Aydın University |
| Condition | Hemodialysis Complication |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2025-12-01 |
| Primary Completion | 2026-04-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2025-12-01 with a primary completion date of 2026-04-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to evaluate the effects of progressive muscle relaxation exercises on depression and fatigue levels in patients undergoing hemodialysis treatment. Progressive muscle relaxation is applied as an individualized non-pharmacological intervention, and its potential contribution to psychological well-being is investigated. The study seeks to determine whether regular relaxation exercises can reduce depressive symptoms, alleviate fatigue, and improve overall emotional well-being in hemodialysis patients. Findings from this research are expected to provide evidence for the use of relaxation-based interventions as supportive care methods in the management of psychological symptoms associated with chronic kidney disease and hemodialysis.
Eligibility Criteria
Inclusion Criteria: Scoring 4 or above on the First-Level Beck Depression Inventory Patients who regularly receive hemodialysis treatment Individuals who are cognitively capable of understanding the exercise instructions Individuals who voluntarily agree to participate in the study and provide informed consent Exclusion Criteria: Individuals diagnosed with a psychiatric disorder (e.g., major depression, bipolar disorder, schizophrenia, etc.) Individuals who are physically unable to perform relaxation exercises due to musculoskeletal disorders Individuals who have previously participated regularly in relaxation therapy, yoga, meditation, or similar practices Individuals who cannot follow instructions due to hearing, visual, or cognitive impairments Individuals who are simultaneously participating in another psychosocial or physical intervention program \-
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07512895 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Hemodialysis Complication. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07512895 currently recruiting?
Yes, NCT07512895 is actively recruiting participants. Contact the research team at arzukavala@aydin.edu.tr for enrollment information.
Where is the NCT07512895 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye), Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT07512895 clinical trial?
NCT07512895 is sponsored by Istanbul Aydın University. The trial plans to enroll 60 participants.